SV hasn't opened yet I suspect because of an order imbalance to the upside. Meanwhile this is from DJ.
"...Insite Vision Licenses Eye Tech To Pharmacia & Upjohn
ALAMEDA, Calif. -- Insite Vision Inc. (ISV) gave Pharmacia & Upjohn Inc. (PNU) exclusive license to its ISV-900 technology, which tests for multiple genetic markers associated with glaucoma.
In a press release Thursday, Insite said the agreement includes a license fee, on-going research support payments, an equity investment, a credit line and milestone payments with a possible value of $19 million, plus royalties.
Pharmacia & Upjohn will develop the diagnostic product and have rights to its therapeutic applications.
American Stock Exchange-listed Insite Vision shares closed Thursday at 2 1/16, up 5/16, or 17.9%, on composite volume of 205,500 shares. Daily average volume is 58,726 shares..."
|
